Abstract
Changes in the management of cardiac transplant recipients over the past 10 years have resulted in a substantial improvement in the outlook for survival. Imuran and prednisone remain the primary immunosuppressive agents, but rabbit antihuman thymocyte globulin is used initially and reinstituted during rejection. Endomyocardial biopsy has allowed more precise diagnosis and management of rejection, and more recently immunological monitoring has been introduced to provide more frequent assessment of the host immune response. Infection is the major cause of death, and its diagnosis and treatment is managed aggressively. Current survival figures justify the use of cardiac transplantation, by an experienced team, when other measures have been exhausted.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bieber C. P., Griepp R. B., Oyer P. E., David L. A., Stinson E. B. Relationship of rabbit ATG serum clearance rate to circulating T-cell level, rejection onset, and survival in cardiac transplantation. Transplant Proc. 1977 Mar;9(1):1031–1036. [PubMed] [Google Scholar]
- Bieber C. P., Griepp R. B., Oyer P. E., Wong J., Stinson E. B. Use of rabbit antithymocyte globulin in cardiac transplantation. Relationship of serum clearance rates to clinical outcome. Transplantation. 1976 Nov;22(5):478–488. doi: 10.1097/00007890-197611000-00011. [DOI] [PubMed] [Google Scholar]
- Bieber C. P., Lydick E., Griepp R. B., David L. A., Oyer P. E., Stinson E. B. Radioimmune assay of heterologous serum gamma-globulin in patients receiving rabbit antihuman thymocyte globulin. Transplantation. 1975 Nov;20(5):393–398. doi: 10.1097/00007890-197511000-00006. [DOI] [PubMed] [Google Scholar]
- Caves P. K., Stinson E. B., Billingham M. E., Rider A. K., Shumway N. E. Diagnosis of human cardiac allograft rejection by serial cardiac biopsy. J Thorac Cardiovasc Surg. 1973 Sep;66(3):461–466. [PubMed] [Google Scholar]
- Griepp R. B., Stinson E. B., Bieber C. P., Oyer P. E., Reitz B. A., Copeland J. G., Shumway N. E. Heart and other organs. Increasing patient survival following heart transplantation. Transplant Proc. 1977 Mar;9(1):197–201. [PubMed] [Google Scholar]
- Griepp R. B., Stinson E. B., Bieber C. P., Reitz B. A., Copeland J. G., Oyer P. E., Shumway N. E. Control of graft arteriosclerosis in human heart transplant recipients. Surgery. 1977 Mar;81(3):262–269. [PubMed] [Google Scholar]
- Krikorian J. G., Anderson J. L., Bieber C. P., Penn I., Stinson E. B. Malignant neoplasms following cardiac transplantation. JAMA. 1978 Aug 18;240(7):639–643. [PubMed] [Google Scholar]
- Stinson E. B., Dong E., Jr, Bieber C. P., Schroeder J. S., Shumway N. E. Cardiac transplantation in man. I. Early rejection. JAMA. 1969 Mar 24;207(12):2233–2247. [PubMed] [Google Scholar]